Impact of Dupilumab on Bone Mineralization Biomarker and Growth Metrics in Children Aged 2 to Under 12 Years With Moderate-to-Severe Atopic Dermatitis
SKIN The Journal of Cutaneous Medicine · 10.11.2026 · 10 (6) · s843
DOI: 10.25251/6zq76e36 ↗Kurz gefasst
Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 10.11.2026. Verfasst von Alan D. Irvine und 10 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective: To assess the effects of dupilumab on serum T-ALP levels (as a proxy for bone mineralization) and height among children aged 2 to
Zitieren
APA
Irvine, A. D., Paller, A. S., Siegfried, E. C., Cork, M. J., Beck, L. A., Ma, L., Staiano, A., You, X., Levy, S., Prescilla, R., & Cyr, S. L. (2026). Impact of Dupilumab on Bone Mineralization Biomarker and Growth Metrics in Children Aged 2 to Under 12 Years With Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, 10(6), s843. https://doi.org/10.25251/6zq76e36
Vancouver
Irvine AD, Paller AS, Siegfried EC, Cork MJ, Beck LA, Ma L, et al. Impact of Dupilumab on Bone Mineralization Biomarker and Growth Metrics in Children Aged 2 to Under 12 Years With Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 2026;10(6):s843. doi:10.25251/6zq76e36
BibTeX
@article{Irvine2026,
author = {Irvine, Alan D. and Paller, Amy S. and Siegfried, Elaine C. and Cork, Michael J. and Beck, Lisa A. and Ma, Lin and Staiano, Annamaria and You, Xiaojun and Levy, Stephane and Prescilla, Randy and Cyr, Sonya L.},
title = {Impact of Dupilumab on Bone Mineralization Biomarker and Growth Metrics in Children Aged 2 to Under 12 Years With Moderate-to-Severe Atopic Dermatitis},
journal = {SKIN The Journal of Cutaneous Medicine},
year = {2026},
volume = {10},
number = {6},
pages = {s843},
doi = {10.25251/6zq76e36}
}
EUVIMED